Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14365/5706
Title: Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD
Authors: Siriratnam, P.
Huda, S.
Van, Der, Walt, A.
Sanfilippo, P.G.
Sharmin, S.
Foong, Y.C.
Yeh, W.Z.
Keywords: Adult
Aquaporin 4
Autoantibodies
Cohort Studies
Disability Evaluation
Disease Progression
Female
Humans
Immunoglobulin G
Male
Middle Aged
Neuromyelitis Optica
Prevalence
Recurrence
Retrospective Studies
AQP4 protein, human
aquaporin 4
autoantibody
immunoglobulin G
adult
blood
clinical trial
cohort analysis
disability assessment
disease exacerbation
epidemiology
female
human
immunology
male
middle aged
multicenter study
myelooptic neuropathy
prevalence
recurrent disease
retrospective study
Abstract: OBJECTIVES: In aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-IgG NMOSD), disability accrual is mostly attributed to relapses. This study aimed to assess the prevalence of progression independent of relapse activity (PIRA) and relapse-associated worsening (RAW) in AQP4-IgG NMOSD. METHODS: This was a retrospective cohort study of patients with AQP4-IgG NMOSD enrolled in the MSBase international data registry. Patients required a minimum of 3 recorded Expanded Disability Status Scale (EDSS) scores: baseline, event, and a 6-month confirmation score. Presence and absence of relapses between the baseline and event EDSS scores determined RAW and PIRA, respectively. Descriptive statistics were used to present the results. RESULTS: A total of 181 patients followed for a median of 4.5 years (Q1 1.7, Q3 7.8) were included. Most patients were female (88.4%), and the median age at disease onset was 38.1 years. Overall, 4 patients (2.2%) developed 5 incidences of PIRA and 13 patients developed RAW (7.2%). DISCUSSION: This multicenter study highlights that PIRA is very rare in AQP4-IgG NMOSD. Limitations of this study include the sole focus of overall EDSS to measure disability, lack of requirement for a second EDSS score to confirm baseline EDSS, and the absence of magnetic resonance imaging information for all patients.
URI: https://doi.org/10.1212/WNL.0000000000209940
https://hdl.handle.net/20.500.14365/5706
ISSN: 1526-632X
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection

Show full item record



CORE Recommender

Page view(s)

14
checked on Jan 6, 2025

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.